2020
DOI: 10.21769/bioprotoc.3506
|View full text |Cite
|
Sign up to set email alerts
|

Transcervical Mouse Infections with Chlamydia trachomatis and Determination of Bacterial Burden

Abstract: Bio-protocol 10(03): e3506.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“… 64 , 68 To address these limitations, an intracervical murine infection model has been developed in which C. trachomatis infection in mice upper genital tract can be established. 62 , 69 We aim to use this model to evaluate the efficacy of the OMV vaccine formulations, both individually and in combination, including the exploration of a single, bivalent formulation incorporating both C. trachomatis antigens coupled to the same OMV. 70 …”
Section: Discussionmentioning
confidence: 99%
“… 64 , 68 To address these limitations, an intracervical murine infection model has been developed in which C. trachomatis infection in mice upper genital tract can be established. 62 , 69 We aim to use this model to evaluate the efficacy of the OMV vaccine formulations, both individually and in combination, including the exploration of a single, bivalent formulation incorporating both C. trachomatis antigens coupled to the same OMV. 70 …”
Section: Discussionmentioning
confidence: 99%
“…A likely explanation for this discrepancy is the repeated observation that murine intravaginal infections with C. trachomatis fail to ascend into the upper genital tract and are readily cleared by the innate immune system ( 82 , 83 ). That being said, recent work has demonstrated transcervical infections with C. trachomatis serovar D severely impact fertility in the mouse model ( 84 , 85 ), emphasizing the importance of infection of cervical epithelial cells to the development of chlamydial sequelae. Intriguingly, the immune response to transcervical C. trachomatis infections includes robust recruitment of CD4+ T-cells and secretion of IL-17 ( 85 , 86 )—features consistent with the cell type-intrinsic induction of IL-17 expression and CD4+ T-cell survival and chemotactic factors (e.g., IL-6 and IL-8) we observe in both uninfected and infected HCECs.…”
Section: Discussionmentioning
confidence: 99%
“…However, the intensity of infection induced by C. muridarum is acute whereas that of C. trachomatis is known to be chronic, and the IFNγ mediated bacterial clearance mechanisms of both these species also differ, thereby making the comparison inaccurate [41,42]. When C. trachomatis is used for inducing vaginal infection in a mouse model, it does not lead to ascending genital tract infection and fallopian tube pathology as seen in humans, making the model imperfect [43]. Recently, a trans cervical method of infection was adopted to facilitate development of an ascending infection in uterus and fallopian tubes, allowing duplication of human infection conditions [38,43].…”
Section: Preclinical Evaluation Of Vaccine Candidatesmentioning
confidence: 99%
“…When C. trachomatis is used for inducing vaginal infection in a mouse model, it does not lead to ascending genital tract infection and fallopian tube pathology as seen in humans, making the model imperfect [43]. Recently, a trans cervical method of infection was adopted to facilitate development of an ascending infection in uterus and fallopian tubes, allowing duplication of human infection conditions [38,43]. C. trachomatis and C. suis have been found to induce homo-and heterologous IFNγ + TNFα + CD4 T cell based immune responses in pigs, indicating possibility of cross-protection between them and humans [44].…”
Section: Preclinical Evaluation Of Vaccine Candidatesmentioning
confidence: 99%